| Literature DB >> 25982104 |
Pooria Salari1, Lisa K Cannada2, Berton R Moed3.
Abstract
BACKGROUND: Following treatment of a posterior pelvic disruption, residual deformity or associated injuries can adversely affect functional recovery. No study has been performed on gait and functional outcome after closed reduction and percutaneous screw fixation (CRPSF) of posterior pelvic disruption in clinically asymptomatic patients. The purpose of this study was to determine if gait and functional outcome are different from normal in asymptomatic patients with a posterior pelvic injury after CRPSF, serving as a pilot study in this regard.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25982104 PMCID: PMC4438342 DOI: 10.1186/s13018-015-0190-z
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Figure 1This lateral view of a study subject during gait evaluation shows several reflective markers placed on the pelvis, thighs, legs, and feet for motion analysis.
Gait parameters of the study and control groups measured using the Dartfish™ software
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
| Injured | 8.7 ± 0.36 | 35.6 ± 6.3 | 11.1 ± 3.0 | 12.0 ± 7.4 | 10.7 ± 5.7 | 14.7 ± 7 | 3.7 ± 2.4 | 1.0 ± 0.2 |
| Uninjured | 9.4 ± 1.7 | 38.1 ± 3.3 | 8.9 ± 3.7 | 11.7 ± 4.8 | 9.8 ± 4.2 | 13.5 ± 4 | 0.17 ± 0.4 | 1.0 ± 0.2 |
| Right side (control group) | 9.8 ± 1.9 | 38.2 ± 3.6 | 4.9 ± 1.4 | 7.8 ± 3.9 | 7.0 ± 4.0 | 9.3 ± 4.5 | 2.7 ± 1.4 | 1.2 ± 0.06 |
| Left side (control group) | 10.1 ± 2 | 38.1 ± 4.6 | 5 ± 2.7 | 6.8 ± 5 | 6.4 ± 4.8 | 8.4 ± 4.9 | 2.2 ± 1.6 | 1.2 ± 0.05 |
DFDS maximum foot dorsiflexion during stance, KFDS maximum knee flexion during stance, KAIC knee angle at initial contact, PTMS pelvic tilt at midstance, PTIC pelvic tilt at initial contact, PTHO pelvic tilt at heel off, PD pelvic drop, SL stride length.
*KAIC greater on the injured side in the SG when compared to the right and left sides in the CG (p < 0.018).
†PD smaller on the uninjured side when compared to the injured side in the SG (p = 0.028) and to either side in the CG (p < 0.038).
SF-12v2 questionnaire scores for the study group versus the control group
|
|
| ||||
|---|---|---|---|---|---|
|
|
|
|
| ||
| SF-12v2 | PCS* | 53.1 | 4.9 | 57.2 | 0.13 |
| MCS† | 53 | 4.8 | 54.8 | 2.6 | |
*p = 0.038, † p = 0.146.
SF-12v2 questionnaire scores for the study group compared to national mean scores for the age group
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| 1 | 18–24 | 50.9 | 53 | 46.6 | 46 |
| 2 | 25–34 | 52.8 | 53.3 | 49.6 | 48.9 |
| 3 | 35–44 | 56.6 | 52 | 60.8 | 48.8 |
| 4 | 35–44 | 44.5 | 52 | 54 | 48.8 |
| 5 | 45–54 | 56.9 | 49.4 | 54.7 | 49.9 |
| 6 | 65–74 | 57.3 | 43 | 52.8 | 51.6 |
aSee [33].
Iowa and Majeed outcome scores for the study group versus the control group
|
|
|
| ||
|---|---|---|---|---|
|
|
|
|
| |
| Iowa* | 95 | 5.5 | 100 | 0 |
| Majeed† | 98 | 2.6 | 100 | 0 |
*p = 0.022, † p = 0.366.